News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Trump Nominates Warsh and Sets 15% Growth Target; Alphabet Issues $20 Billion Bonds; US Tech Stocks Rebound (February 10, 2026)2Bitmine buys $84 million in ETH as Tom Lee calls market pullback 'attractive' entry point: onchain data3As Palantir Projects a 61% Increase in Revenue for 2026, Is Now the Time to Invest in Palantir Shares?
XRP Price Prediction: The Realistic Path to $5 by 2030 – Expert Analysis
Bitcoinworld·2026/02/06 05:27
Kalshi Insider Trading Crackdown: Crucial New Rules Target Super Bowl Betting Integrity
Bitcoinworld·2026/02/06 05:27
Spot Bitcoin ETFs Face Staggering $434.3M Outflow as Investor Sentiment Shifts
Bitcoinworld·2026/02/06 05:27

XRP’s Wave 3 Incoming? Egrag Crypto Calls RSI Drop a Momentum Reset
CoinEdition·2026/02/06 05:27
Pieverse and TermMax Partner to Launch AI-Driven Fixed-Rate Yields for Agentic DeFi
BlockchainReporter·2026/02/06 05:00
Peter Schiff taunts Strategy as Bitcoin bet turns red
Grafa·2026/02/06 04:39

XRP retraces 61% from its peak – But THIS signal hints at deeper trouble
AMBCrypto·2026/02/06 04:03
Pump.fun acquires Vyper to expand cross-chain trading terminal
The Block·2026/02/06 03:30
Japan's biggest banks ready to increase JGB holdings despite growing losses
101 finance·2026/02/06 03:15
Flash
08:01
Denmark's January inflation rate falls to a 21-month low⑴ Denmark's annual inflation rate fell to 0.8% in January 2026, down from the previous value of 1.9%. ⑵ This is the lowest level since April 2024, mainly due to declines in housing and utilities prices (-1.3%, previous +1.2%) and transportation prices (-0.2%, previous +1.3%). ⑶ Meanwhile, the price growth of restaurants and hotels (1.4%, previous 3.3%), information and communication (3.5%, previous 4%), and other miscellaneous goods and services (2.4%, previous 3.3%) also slowed down. ⑷ On the other hand, inflation for food and non-alcoholic beverages edged up to 3.8%, from the previous 3.6%; inflation for recreation and culture slightly increased to 1.9%, from 1.8%. ⑸ On a month-on-month basis, consumer prices fell by 0.6% in January, after declining by 0.4% for two consecutive months. ⑹ Excluding energy and unprocessed food, the core inflation rate dropped to 1.9% in January, the lowest in seven months, after holding steady at 2.3% for the previous three months.
07:50
Spark co-founder Sam MacPherson: The next wave of DeFi growth will depend on integrated protocols that can consolidate multi-chain liquidity, feature institutional-grade risk controls, and have sustainable tokenomics.According to ChainCatcher, at the recent "Build and Scale in 2026" themed forum held by ChainCatcher in Hong Kong, Spark co-founder Sam MacPherson delivered a keynote speech on "The Growth Engine of DeFi," systematically explaining how Spark integrates savings, lending, and institutional-grade capital allocation to build an integrated solution that addresses the fragmentation and inefficiency of on-chain capital markets. Sam MacPherson pointed out that the current on-chain capital market still faces severe fragmentation and low capital utilization efficiency. Spark builds its growth engine through three core products: First, the cross-chain savings account Spark Savings, which manages over $2.75 billions in deposits and provides users with a secure and stable yield entry; second, the blue-chip asset-focused lending protocol SparkLend, which achieves value capture by reducing external protocol commissions and protocol fees; third, institutional lending in cooperation with Anchorage, seeking risk-adjusted returns among DeFi, CeFi, and traditional finance. He believes that the next phase of DeFi growth will depend on integrated protocols that can seamlessly aggregate multi-chain liquidity, provide institutional-grade risk control, and possess a sustainable token economic model. Spark is driving DeFi toward greater efficiency and robustness through its product matrix and ecosystem development.
07:45
AstraZeneca's product sales are expected to grow by 9% to over $55.5 billion in 2025, with growth momentum anticipated to continue this year.Glonghui, February 10th|British pharmaceutical giant AstraZeneca announced its 2025 results, with total annual revenue reaching $58.739 billions, an 8% year-on-year increase at constant exchange rates, mainly driven by growth in oncology, cardiovascular, and rare disease business segments; among them, product sales amounted to $55.573 billions, a 9% year-on-year increase; core earnings per share were $9.16, up 11% year-on-year. For the fourth quarter of 2025, total revenue was $15.503 billions, a 2% year-on-year increase; core earnings per share were $2.12, down 2% year-on-year. AstraZeneca CEO Pascal Soriot stated: "In 2025, the company achieved strong commercial performance across all therapeutic areas, and the R&D pipeline progressed smoothly. The company announced 16 positive Phase III clinical trial results and currently has 16 blockbuster drugs. Looking ahead to 2026, the company will continue to maintain its growth momentum and expects to announce results from more than 20 Phase III clinical trials this year." The company announced a second interim dividend of $2.17 per share; the total dividend for 2025 increased by 3% to $3.2 per share. Looking ahead to 2026, AstraZeneca expects total revenue to achieve mid-to-high single-digit percentage growth, and core earnings per share to achieve low double-digit percentage growth.
News